Grant: Master's Award - Priority Announcement: HIV Research (SHOPP)
University of Manitoba
$8,750.00
Understanding the role of rectal mucosal fluid in HIV infection and susceptibility in HIV-exposed men who have sex with men
EF 2012-13
Résumé
Men who have sex with men (MSM) are one of the highest risk groups for HIV acquisition, and are a major contributor to the global HIV/AIDS epidemic. Risk of HIV-acquisition is greatest through unprotected anal intercourse (URAI); thus, developing related prevention technologies (microbicides) remains a priority. The rectum produces mucosa as the first line of defense against HIV; but the properties of rectal mucosa (RM) that block HIV infection are understudied and are a major gap in knowledge. Our published studies investigating HIV-exposed seronegative (HESN) individuals-those repeatedly exposed to HIV, but remain uninfected-have associated antiviral proteins bPRP2 and Serpins with the protected HESN phenotype in the oral and vaginal mucosa, respectively, and are helping to guide microbicide research. These finding strongly support the need to study protein factors within mucosa, and defining these proteins in the RM of HESN MSM would help advance microbicides that prevent high-risk HIV transmission through URAI.
Our preliminary proteomics data has characterized >300 proteins within RM, including proteins associated with HIV-susceptibility, and identified RM as unique from vaginal/oral mucusa. Our comparison of HESN MSM to control individuals revealed that HESN MSM overexpress the anti-HIV protein DMBT1. We have also shown that RM can inhibit HIV infection in vitro by 40%. Thus, my hypothesis is that DMBT1 and other protein factors of the rectal mucosa are associated with HIV-protection.
This hypothesis will be tested with further proteomic characterization of HESN MSM vs. non-exposed MSM controls to validate DMBT1 and find other correlated proteins, evaluation of the antiviral properties of RM during mock infections of human cells, and by testing the antiviral properties of DMBT1 in cell culture.
This novel, comprehensive study will significantly increase our understanding of the immunobiology of the rectal tract and will shape microbicide research.
Programme
Master's Award - Priority Announcement: HIV Research (SHOPP)
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
284435
Name
Romas Laura M
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association for HIV Research (Ottawa); Bristol-Myers Squibb Canada (Montreal, Quebec); ViiV Healthcare (Laval, Québec)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Understanding the role of rectal mucosal fluid in HIV infection and susceptibility in HIV-exposed men who have sex with men
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$8,750
Cihrequipment2
$0
Programname2
Master's Award - Priority Announcement: HIV Research (SHOPP)
Keyworddelim
Human Immunodeficiency Virus; Mass Spectrometry; Men Who Have Sex With Men; Microbicide; Msm; Mucosal Immunology; Proteomics; Transmission; Urai
Abstract
Men who have sex with men (MSM) are one of the highest risk groups for HIV acquisition, and are a major contributor to the global HIV/AIDS epidemic. Risk of HIV-acquisition is greatest through unprotected anal intercourse (URAI); thus, developing related prevention technologies (microbicides) remains a priority. The rectum produces mucosa as the first line of defense against HIV; but the properties of rectal mucosa (RM) that block HIV infection are understudied and are a major gap in knowledge. Our published studies investigating HIV-exposed seronegative (HESN) individuals-those repeatedly exposed to HIV, but remain uninfected-have associated antiviral proteins bPRP2 and Serpins with the protected HESN phenotype in the oral and vaginal mucosa, respectively, and are helping to guide microbicide research. These finding strongly support the need to study protein factors within mucosa, and defining these proteins in the RM of HESN MSM would help advance microbicides that prevent high-risk HIV transmission through URAI.
Our preliminary proteomics data has characterized >300 proteins within RM, including proteins associated with HIV-susceptibility, and identified RM as unique from vaginal/oral mucusa. Our comparison of HESN MSM to control individuals revealed that HESN MSM overexpress the anti-HIV protein DMBT1. We have also shown that RM can inhibit HIV infection in vitro by 40%. Thus, my hypothesis is that DMBT1 and other protein factors of the rectal mucosa are associated with HIV-protection.
This hypothesis will be tested with further proteomic characterization of HESN MSM vs. non-exposed MSM controls to validate DMBT1 and find other correlated proteins, evaluation of the antiviral properties of RM during mock infections of human cells, and by testing the antiviral properties of DMBT1 in cell culture.
This novel, comprehensive study will significantly increase our understanding of the immunobiology of the rectal tract and will shape microbicide research.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Romas, Laura M
Approvedterm
1 an 0 mois
Cihrcontribution2
SPIR~ $8,750~ $0~